Olmesartan EP Impurity D is a synthetic byproduct formed via an alternative condensation pathway during olmesartan synthesis. It retains the core benzimidazole-tetrazole pharmacophore but incorporates an additional aromatic ester linkage and a substituted biphenyl moiety, distinguishing it from the parent compound. The structure includes multiple conjugated aromatic systems, amide bonds, and a terminal carboxylic acid ester, conferring unique UV absorption and HPLC retention characteristics. This impurity functions as a reference standard for detecting process-related deviations in olmesartan intermediate purification.
